InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ordonez Claudia, Directeur Médical. Officer active across 1 company, notably Keros Therapeutics, Inc.. Cumulatively, 2 filings have been recorded. History available since 11 May 2021. The latest transaction was filed on 11 June 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ordonez Claudia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,000 shares@ US$0.4849.9% of flowCommon StockSEC:0001209191-21-040648:0
1,000 shares@ US$0.4850.1% of flowCommon StockSEC:0001209191-21-032361:0
2 of 2 declarations
About Ordonez Claudia
Claudia Ordonez is Chief Medical Officer at Keros Therapeutics, Inc., a biopharmaceutical company. She is responsible for medical strategies and clinical operations. Her expertise in medicine and research is essential for the development of new treatments.
